- Home
- TSBX vs MNTS Comparison
TSBX vs MNTS Comparison
Compare TSBX & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- MNTS
- Stock Information
- Founded
- TSBX 2015
- MNTS 2017
- Country
- TSBX United States
- MNTS United States
- Employees
- TSBX N/A
- MNTS N/A
- Industry
- TSBX
- MNTS Military/Government/Technical
- Sector
- TSBX
- MNTS Industrials
- Exchange
- TSBX Nasdaq
- MNTS Nasdaq
- Market Cap
- TSBX 7.7M
- MNTS 6.6M
- IPO Year
- TSBX 2023
- MNTS N/A
- Fundamental
- Price
- TSBX $0.37
- MNTS $1.25
- Analyst Decision
- TSBX Buy
- MNTS
- Analyst Count
- TSBX 3
- MNTS 0
- Target Price
- TSBX $4.75
- MNTS N/A
- AVG Volume (30 Days)
- TSBX 469.1K
- MNTS 3.0M
- Earning Date
- TSBX 08-13-2025
- MNTS 05-15-2025
- Dividend Yield
- TSBX N/A
- MNTS N/A
- EPS Growth
- TSBX N/A
- MNTS N/A
- EPS
- TSBX N/A
- MNTS N/A
- Revenue
- TSBX N/A
- MNTS $1,923,000.00
- Revenue This Year
- TSBX N/A
- MNTS $286.00
- Revenue Next Year
- TSBX N/A
- MNTS N/A
- P/E Ratio
- TSBX N/A
- MNTS N/A
- Revenue Growth
- TSBX N/A
- MNTS N/A
- 52 Week Low
- TSBX $0.29
- MNTS $1.03
- 52 Week High
- TSBX $2.69
- MNTS $28.56
- Technical
- Relative Strength Index (RSI)
- TSBX 53.53
- MNTS 36.42
- Support Level
- TSBX $0.33
- MNTS $1.08
- Resistance Level
- TSBX $0.37
- MNTS $1.27
- Average True Range (ATR)
- TSBX 0.02
- MNTS 0.17
- MACD
- TSBX 0.00
- MNTS -0.00
- Stochastic Oscillator
- TSBX 60.17
- MNTS 17.24
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
About MNTS Momentus Inc.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.